The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An open-label phase Ib study to determine safety and preliminary efficacy of oral Lucitanib (AL3810) in patients with locally advanced or metastatic gastric, hepatocellular, nasopharyngeal carcinoma, malignant biliary, and thymic tumors.
 
Hongming Pan
No Relationships to Disclose
 
Shukui Qin
No Relationships to Disclose
 
Li Zhang
No Relationships to Disclose
 
Jin Li
No Relationships to Disclose
 
Jianming Xu
No Relationships to Disclose
 
Ruihua Xu
No Relationships to Disclose